Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:43AM EST. Market open.
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-153,420
-250,157
-65,578
-89,127
-70,279
Depreciation & amortisation
6,301
6,629
5,947
6,578
7,603
Stock-based compensation
33,997
25,482
20,222
8,824
8,344
Change in working capital
-26,652
-18,391
41,530
-23,197
-24,627
Accounts receivable
-
0
9,387
-7,602
-1,785
Accounts payable
-1,598
2,203
9,362
-1,159
-1,460
Other working capital
-133,083
-238,637
-2,878
-94,201
-77,522
Other non-cash items
15,302
6,933
2,041
3,312
2,336
Net cash provided by operating activities
-123,074
-228,816
6,688
-93,610
-76,520
Cash flows from investing activities
Investments in property, plant and equipment
-10,009
-9,821
-9,566
-591
-1,002
Purchases of investments
-16,509
-48,221
-95,971
-218,284
-46,420
Sales/maturities of investments
85,831
140,470
169,625
59,984
16,904
Net cash used for investing activities
59,313
82,428
64,088
-158,891
-30,518
Cash flows from financing activities
Debt repayment
-52,860
-1,907
-948
-
-
Common stock issued
112,898
101,168
0
268,641
61,215
Common stock repurchased
-
-
-
0
0
Other financing activities
-
-
-
19,900
-425
Net cash used provided by (used for) financing activities
166,457
129,602
1,178
303,424
86,231
Net change in cash
102,696
-16,786
71,954
50,923
-20,807
Cash at beginning of period
135,009
188,002
116,049
65,126
85,933
Cash at end of period
237,705
171,215
188,002
116,049
65,126
Free cash flow
Operating cash flow
-123,074
-228,816
6,688
-93,610
-76,520
Capital expenditure
-10,009
-9,821
-9,566
-591
-1,002
Free cash flow
-133,083
-238,637
-2,878
-94,201
-77,522
© 2023 Yahoo. All rights reserved.